FIXED COMBINATION OF THE CALCIUM CHANNEL BLOCKER LERCANIDIPINE AND ANGIOTENSIN CONVERTING ENZYME INHIBITOR ENALAPRIL: POSSIBILITY OF USAGE
<p>Data on the updated approach to the choice of two-component antihypertensive combinations for different clinical situations are presented. Advantages and indications for combination of an angiotensin converting enzyme (ACE) inhibitor and dihydropyridine calcium antagonist are considered. Da...
| Príomhchruthaitheoirí: | , |
|---|---|
| Formáid: | Alt |
| Teanga: | English |
| Foilsithe / Cruthaithe: |
Столичная издательская компания
2015-09-01
|
| Sraith: | Рациональная фармакотерапия в кардиологии |
| Ábhair: | |
| Rochtain ar líne: | http://www.rpcardio.ru/jour/article/view/284 |
Search Result 1